How Genomic Sequencing Can Outperform Standard Newborn Screening Tests
Early results from a new study demonstrate that genomic sequencing identifies significantly more treatable health conditions in newborns.
Read MorePosted by Andy Lundin | Oct 24, 2024 | Molecular Diagnostics |
Early results from a new study demonstrate that genomic sequencing identifies significantly more treatable health conditions in newborns.
Read MorePosted by Andy Lundin | Oct 23, 2024 | Molecular Diagnostics, Urinalysis & Toxicology |
Researchers are exploring urine analysis as a tool for early detection of diseases by studying RNA and other substances in urine.
Read MorePosted by Andy Lundin | Oct 22, 2024 | Lung Cancer, Molecular Diagnostics |
NeoGenomics received conditional approval from the New York State Department of Health for its Neo Comprehensive Solid Tumor and NeoTYPE DNA & RNA Lung assays.
Read MorePosted by Andy Lundin | Oct 22, 2024 | Molecular Diagnostics, Swabs |
OralDNA Labs acquired Sensible Diagnostics to enhance its rapid point-of-care molecular diagnostic testing capabilities.
Read MorePosted by Andy Lundin | Oct 21, 2024 | Allergy & Autoimmune |
Augurex Life Sciences and ARUP Labs collaborated on a test to detect rheumatoid arthritis for improved early diagnostic capabilities.
Read More